Page last updated: 2024-10-19

thioctic acid and Bone Demineralization, Pathologic

thioctic acid has been researched along with Bone Demineralization, Pathologic in 1 studies

Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.

Bone Demineralization, Pathologic: Decrease, loss, or removal of the mineral constituents of bones. Temporary loss of bone mineral content is especially associated with space flight, weightlessness, and extended immobilization. OSTEOPOROSIS is permanent, includes reduction of total bone mass, and is associated with increased rate of fractures. CALCIFICATION, PHYSIOLOGIC is the process of bone remineralizing. (From Dorland, 27th ed; Stedman, 25th ed; Nicogossian, Space Physiology and Medicine, 2d ed, pp327-33)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, SH1
Kim, MJ1
Kim, BJ1
Kim, SR1
Chun, S1
Ryu, JS1
Kim, GS1
Lee, MC1
Koh, JM1
Chung, SJ1

Trials

1 trial available for thioctic acid and Bone Demineralization, Pathologic

ArticleYear
Homocysteine-lowering therapy or antioxidant therapy for bone loss in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2010, Feb-15, Volume: 25, Issue:3

    Topics: Absorptiometry, Photon; Aged; Analysis of Variance; Anthropometry; Antioxidants; Bone Demineralizati

2010